公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2007 | Targeting neuropilin 1 as an antitumor strategy in lung cancer | Hong, T.-M.; Chen Y.-L.; Wu, Y.-Y.; ANG YUAN ; Chao, Y.-C.; Chung, Y.-C.; Wu, M.-H.; SHIH-CHIN YANG; SZU-HUA PAN ; JIN-YUAN SHIH ; Chan W.-K.; PAN-CHYR YANG | Clinical Cancer Research | 178 | 153 | |
2020 | Targeting positive feedback between BASP1 and EGFR as a therapeutic strategy for lung cancer progression | Lin C.-C.; Huang Y.-K.; Cho C.-F.; Lin Y.-S.; Lo C.-C.; Kuo T.-T.; Tseng G.-C.; Cheng W.-C.; Chang W.-C.; Hsiao T.-H.; Liang-Chuan Lai ; JIN-YUAN SHIH ; Liu Y.-H.; Clifford Chao K.S.; Hsu J.L.; Lee P.-C.; Sun X.; Hung M.-C.; Sher Y.-P. | Theranostics | 19 | 15 | |
2017 | Targeting RET in patients with RET-rearranged lung cancers: Results from the global, multicenter RET registry | Gautschi O.; Milia J.; Filleron T.; Wolf J.; Carbone D.P.; Owen D.; Camidge R.; Narayanan V.; Doebele R.C.; Besse B.; Remon-Masip J.; Janne P.A.; Awad M.M.; Peled N.; Byoung C.-C.; Karp D.D.; Van Den Heuvel M.; Wakelee H.A.; Neal J.W.; Mok T.S.K.; CHIH-HSIN YANG ; Ou S.-H.I.; Pall G.; Froesch P.; Zalcman G.; Gandara D.R.; Riess J.W.; Velcheti V.; Zeidler K.; Diebold J.; Früh M.; Michels S.; Monnet I.; Popat S.; Rosell R.; Karachaliou N.; Rothschild S.I.; JIN-YUAN SHIH ; Warth A.; Muley T.; Cabillic F.; Mazières J.; Drilon A. | Journal of Clinical Oncology | 279 | 249 | |
2011 | Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: The association with treatment efficacy of pemetrexed | CHUNG-YU CHEN ; YIH-LEONG CHANG ; JIN-YUAN SHIH ; JOU-WEI LIN ; KUAN-YU CHEN ; CHIH-HSIN YANG ; CHONG-JEN YU ; PAN-CHYR YANG | Lung Cancer | 108 | 102 | |
2020 | Time to be familiar with nontuberculous mycobacterial lung disease - An emerging disease with diverse clinical outcomes | JANN-YUAN WANG ; JIN-YUAN SHIH ; Lin M.-C. | Journal of the Formosan Medical Association | 2 | 0 | |
2024 | Tissue or liquid rebiopsy? A prospective study for simultaneous tissue and liquid NGS after first-line EGFR inhibitor resistance in lung cancer | YEN-TING LIN ; CHAO-CHI HO ; Hsu, Wei-Hsun; WEI-YU LIAO ; CHING-YAO YANG ; CHONG-JEN YU ; TZU-HSIU TSAI ; CHIH-HSIN YANG ; SHANG-GIN WU ; CHIA-LIN HSU ; Hsieh, Min-Shu; YEN-LIN HUANG ; Wu, Chia-Ling; JIN-YUAN SHIH | Cancer medicine | 0 | | |
2022 | Toll-like receptor and matrix metalloproteinase single-nucleotide polymorphisms, haplotypes, and polygenic risk score differentiated between tuberculosis disease and infection | MENG-RUI LEE ; YEN-LIN CHEN ; Wu, Chang-Wei; LUN-CHE CHEN ; LIH-YU CHANG ; Chen, Jung-Yueh; YU-TSUNG HUANG ; JANN-YUAN WANG ; JIN-YUAN SHIH ; CHONG-JEN YU | International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2 | 2 | |
1998 | Tracheal botryomycosis in a patient with tracheopathia osteochondroplastica | JIN-YUAN SHIH ; PO-REN HSUEH ; YIH-LEONG CHANG ; LI-NA LEE ; YEE-CHUN CHEN ; MING-FONG CHEN ; KWEN-TAY LUH | Thorax | 21 | 16 | |
2021 | Trait mindfulness and depressive symptoms in non-small cell lung cancer patients: the mediating roles of quality of life and meaning in life | Hsieh C.-C.; CHAO-CHI HO ; ZHONG-ZHE LIN ; CHONG-JEN YU ; Jow G.-M.; Huang F.-Y.; JIN-YUAN SHIH ; FEI-HSIU HSIAO | Psychology and Health | 2 | 4 | |
2005 | Transcription repressor Slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma | JIN-YUAN SHIH ; Tsai M.-F.; Chang T.-H.; YIH-LEONG CHANG ; ANG YUAN ; CHONG-JEN YU ; Lin S.-B.; Liou G.-Y.; Lee M.-L.; Chen J.J.W.; Hong T.-M.; Yang S.-C.; Su J.-L.; Lee Y.-C.; PAN-CHYR YANG | Clinical Cancer Research | 194 | 184 | |
2015 | Treating patients with ALK-positive non-small cell lung cancer: Latest evidence and management strategy | BIN-CHI LIAO ; CHIA-CHI LIN ; JIN-YUAN SHIH ; CHIH-HSIN YANG | Therapeutic Advances in Medical Oncology | 16 | 16 | |
2018 | Treatment effectiveness and tolerability of afatinib at different doses in patients with EGFR-mutated lung adenocarcinoma: How low can we go? | Lim C.-K.; Wei Y.-F.; Tsai M.-S.; KUAN-YU CHEN ; JIN-YUAN SHIH ; CHONG-JEN YU | European Journal of Cancer | 18 | 14 | |
2021 | Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort | SHENG-KAI LIANG ; LI-TA KENG ; CHIA-HAO CHANG ; Wen, Yueh-Feng; MENG-RUI LEE ; CHING-YAO YANG ; JANN-YUAN WANG ; JEN-CHUNG KO ; JIN-YUAN SHIH ; CHONG-JEN YU | Frontiers in Oncology | 2 | 3 | |
2003 | Tuberculous myositis: A rare but existing clinical entity | JANN-YUAN WANG ; LI-NA LEE ; PO-REN HSUEH ; JIN-YUAN SHIH ; YIH-LEONG CHANG ; PAN-CHYR YANG ; KWEN-TAY LUH | Rheumatology | 68 | 57 | |
2018 | Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan | SHU-YUNG LIN ; Yang C.-Y.; BIN-CHI LIAO ; CHAO-CHI HO ; WEI-YU LIAO ; KUAN-YU CHEN ; TZU-HSIU TSAI ; CHIA-LIN HSU ; Hsu W.-H.; KANG-YI SU ; YIH-LEONG CHANG ; JIH-HSIANG LEE ; CHIA-CHI LIN ; JIN-YUAN SHIH ; CHIH-HSIN YANG ; CHONG-JEN YU | Journal of Cancer | 40 | 41 | |
2003 | Tumor-associated antigen L6 and the invasion of human lung cancer cells | Kao Y.-R.; JIN-YUAN SHIH ; Wen W.-C.; Ko Y.-P.; Chen B.-M.; Chan Y.-L.; Chu Y.-W.; PAN-CHYR YANG ; Wu C.-W.; Roffler S.R. | Clinical Cancer Research | 73 | 70 | |
2022 | Tyrosine Kinase Inhibitor Activity in Patients with NSCLC Harboring Uncommon EGFR Mutations: A Retrospective International Cohort Study (UpSwinG) | Popat S.; Hsia T.-C.; Hung J.-Y.; Jung H.A.; JIN-YUAN SHIH ; Park C.K.; Lee S.H.; Okamoto T.; Ahn H.K.; Lee Y.C.; Sato Y.; Lee S.S.; Mascaux C.; Daoud H.; Märten A.; Miura S. | The oncologist | 14 | 9 | |
2021 | Tyrosine Kinase Inhibitors Improved Survival of Critically Ill EGFR-Mutant Lung Cancer Patients Undergoing Mechanical Ventilation | Lee, I-Hsien; CHING-YAO YANG ; JIN-YUAN SHIH ; CHONG-JEN YU | Biomedicines | 4 | 1 | |
2011 | Unique p53 and epidermal growth factor receptor gene mutation status in 46 pulmonary lymphoepithelioma-like carcinomas | YIH-LEONG CHANG ; CHEN-TU WU ; JIN-YUAN SHIH ; Lee Y.-C. | Cancer Science | 63 | 58 | |
2023 | Upfront liquid next-generation sequencing in treatment-naïve advanced non-small cell lung cancer patients: A prospective randomised study in the Taiwanese health system | CHING-YAO YANG ; JIN-YUAN SHIH ; WEI-YU LIAO ; CHAO-CHI HO ; CHIA-LIN HSU ; TZU-HSIU TSAI ; SHANG-GIN WU ; YEN-TING LIN ; Hsu, Wei-Hsun; Jain, Suyog; Olsen, Steve; CHIH-HSIN YANG ; CHONG-JEN YU ; PAN-CHYR YANG | European journal of cancer (Oxford, England : 1990) | 0 | 0 | |